| Rachel A Adair, CRNP | |
|
2700 Highway 280 S, Mountain Brk, AL 35223-2420 | |
| (205) 878-4368 | |
| Not Available |
| Full Name | Rachel A Adair |
|---|---|
| Gender | Female |
| Speciality | Pain Medicine - Interventional Pain Medicine |
| Location | 2700 Highway 280 S, Mountain Brk, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740858612 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 1-112435 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel A Adair, CRNP 2700 Highway 280 S, Mountain Brk, AL 35223-2420 Ph: () - | Rachel A Adair, CRNP 2700 Highway 280 S, Mountain Brk, AL 35223-2420 Ph: (205) 878-4368 |
News Archive
Using the hemoglobin A1c blood test to diagnose diabetes tends to underestimate the prevalence of the disease, according to a new study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.
Simply getting older is not the cause of mild memory lapses often called senior moments, according to a new study by researchers at the Rush Alzheimer's Disease Center. The study, published in the September 15, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology, found that even the very early mild changes in memory that are much more common in old age than dementia are caused by the same brain lesions associated with Alzheimer's disease and other dementias.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
The Philadelphia Inquirer on Wednesday examined how workplace-based health care centers are "quickly gaining popularity among large employers around the country" who consider them "an attractive perk for employees, but also a way to increase worker productivity and hold down health costs by treating problems early and efficiently."
› Verified 3 days ago